Literature DB >> 9543442

Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice.

N A Roberts1, J C Craig, J Sheldon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543442     DOI: 10.1097/00002030-199805000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.

Authors:  N Dautin; G Karimova; A Ullmann; D Ladant
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Enzymes used in molecular biology: a useful guide.

Authors:  Laure Rittié; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-03       Impact factor: 5.782

Review 3.  Nelfinavir: an update on its use in HIV infection.

Authors:  A Bardsley-Elliot; G L Plosker
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

4.  Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.

Authors:  P Bossi; M Mouroux; A Yvon; F Bricaire; H Agut; J M Huraux; C Katlama; V Calvez
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

5.  Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.

Authors:  N Yahi; C Tamalet; C Tourrès; N Tivoli; F Ariasi; F Volot; J A Gastaut; H Gallais; J Moreau; J Fantini
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 6.  Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.

Authors:  D P Figgitt; G L Plosker
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

Review 7.  Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Authors:  Rob E Aarnoutse; Jonathan M Schapiro; Charles A B Boucher; Yechiel A Hekster; David M Burger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters.

Authors:  Chen-Hsiang Shen; Yuan-Fang Wang; Andrey Y Kovalevsky; Robert W Harrison; Irene T Weber
Journal:  FEBS J       Date:  2010-08-02       Impact factor: 5.542

Review 9.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

10.  Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV.

Authors:  J Kervinen; J Lubkowski; A Zdanov; D Bhatt; B M Dunn; K Y Hui; D J Powell; J Kay; A Wlodawer; A Gustchina
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.